ReviewPolymers2025
Marine Microbial Exopolysaccharides (EPSs): Untapped Bio-Reserves.
Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Antibiotic discovery occurs at a snail's pace, coercing researchers to find novel and promising alternatives to tackle antimicrobial resistance (AMR). Marine microbial exopolysaccharides (EPSs) have emerged as one, considering the recent recognition of these substances as a significant bioactive compound. This manuscript is intended to relate the identified molecular features of marine-driven EPS and applications in the field of biomedical sciences. The current review pointed out the ecological merits of such polymers in agriculture sector. Biochemical structure and the controlling mechanisms of EPS production in marine microbes are considered key features as well. Climate-induced factors impacting the production, composition, and functionality of EPSs are scrutinized. Last but not least, it draws biological insights from medical, industrial, and biotechnology sectors, thereby highlighting their linkage between antimicrobial innovation, industrial biotechnology, and environmental sustainability, while also describing the concerns that need to be resolved, like translation of laboratory results into marketable products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.